CHGCY
Price
$22.25
Change
+$0.06 (+0.27%)
Updated
Sep 5 closing price
Capitalization
73.37B
GIFOF
Price
$8.81
Change
+$0.56 (+6.79%)
Updated
Jun 20 closing price
Capitalization
8.66B
Interact to see
Advertisement

CHGCY vs GIFOF

Header iconCHGCY vs GIFOF Comparison
Open Charts CHGCY vs GIFOFBanner chart's image
Chugai Pharmaceutical
Price$22.25
Change+$0.06 (+0.27%)
Volume$120.49K
Capitalization73.37B
Grifols Sa
Price$8.81
Change+$0.56 (+6.79%)
Volume$112
Capitalization8.66B
CHGCY vs GIFOF Comparison Chart in %
Loading...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCY vs. GIFOF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCY is a Hold and GIFOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CHGCY: $22.25 vs. GIFOF: $8.81)
Brand notoriety: CHGCY and GIFOF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCY: 45% vs. GIFOF: 100%
Market capitalization -- CHGCY: $73.37B vs. GIFOF: $8.66B
CHGCY [@Pharmaceuticals: Major] is valued at $73.37B. GIFOF’s [@Pharmaceuticals: Major] market capitalization is $8.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCY’s FA Score shows that 1 FA rating(s) are green whileGIFOF’s FA Score has 1 green FA rating(s).

  • CHGCY’s FA Score: 1 green, 4 red.
  • GIFOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CHGCY and GIFOF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCY’s TA Score shows that 5 TA indicator(s) are bullish.

  • CHGCY’s TA Score: 5 bullish, 3 bearish.

Price Growth

CHGCY (@Pharmaceuticals: Major) experienced а +1.64% price change this week, while GIFOF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.93%. For the same industry, the average monthly price growth was +4.01%, and the average quarterly price growth was +13.35%.

Industries' Descriptions

@Pharmaceuticals: Major (+0.93% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCY($73.4B) has a higher market cap than GIFOF($8.66B). CHGCY has higher P/E ratio than GIFOF: CHGCY (27.41) vs GIFOF (17.18). GIFOF YTD gains are higher at: 26.289 vs. CHGCY (1.274). CHGCY has higher annual earnings (EBITDA): 556B vs. GIFOF (1.62B). CHGCY has more cash in the bank: 1.03T vs. GIFOF (566M). CHGCY has higher revenues than GIFOF: CHGCY (1.2T) vs GIFOF (7.45B).
CHGCYGIFOFCHGCY / GIFOF
Capitalization73.4B8.66B847%
EBITDA556B1.62B34,363%
Gain YTD1.27426.2895%
P/E Ratio27.4117.18160%
Revenue1.2T7.45B16,062%
Total Cash1.03T566M181,625%
Total DebtN/A8.82B-
FUNDAMENTALS RATINGS
CHGCY vs GIFOF: Fundamental Ratings
CHGCY
GIFOF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9984
PRICE GROWTH RATING
1..100
8155
P/E GROWTH RATING
1..100
6694
SEASONALITY SCORE
1..100
5037

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GIFOF's Valuation (20) in the null industry is in the same range as CHGCY (26). This means that GIFOF’s stock grew similarly to CHGCY’s over the last 12 months.

GIFOF's Profit vs Risk Rating (100) in the null industry is in the same range as CHGCY (100). This means that GIFOF’s stock grew similarly to CHGCY’s over the last 12 months.

GIFOF's SMR Rating (84) in the null industry is in the same range as CHGCY (99). This means that GIFOF’s stock grew similarly to CHGCY’s over the last 12 months.

GIFOF's Price Growth Rating (55) in the null industry is in the same range as CHGCY (81). This means that GIFOF’s stock grew similarly to CHGCY’s over the last 12 months.

CHGCY's P/E Growth Rating (66) in the null industry is in the same range as GIFOF (94). This means that CHGCY’s stock grew similarly to GIFOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCYGIFOF
RSI
ODDS (%)
Bullish Trend 4 days ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
47%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ABOT39.360.33
+0.85%
Abacus FCF Innovation Leaders ETF
CBSE38.580.12
+0.30%
Clough Select Equity ETF
IBUY75.000.18
+0.24%
Amplify Online Retail ETF
IYZ31.960.05
+0.16%
iShares US Telecommunications ETF
FTCS93.17-0.29
-0.31%
First Trust Capital Strength ETF

CHGCY and

Correlation & Price change

A.I.dvisor tells us that CHGCY and CHGCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCY and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
+0.27%
CHGCF - CHGCY
32%
Poorly correlated
+9.42%
OTSKY - CHGCY
30%
Poorly correlated
+2.67%
OPHLY - CHGCY
22%
Poorly correlated
+0.52%
DSNKY - CHGCY
22%
Poorly correlated
-1.06%
RHHBY - CHGCY
20%
Poorly correlated
+0.61%
More

GIFOF and

Correlation & Price change

A.I.dvisor tells us that GIFOF and GIFLF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIFOF and GIFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFOF
1D Price
Change %
GIFOF100%
N/A
GIFLF - GIFOF
30%
Poorly correlated
N/A
GRFS - GIFOF
26%
Poorly correlated
+2.32%
BAYZF - GIFOF
6%
Poorly correlated
+2.92%
CHGCY - GIFOF
5%
Poorly correlated
+0.27%
CSPCY - GIFOF
4%
Poorly correlated
+1.24%
More